Femto Technologies Secures Patent Allowance for Innovative Sensera Wellness Device
Femto Technologies Inc. received a Notice of Allowance from the USPTO for its Sensera device design, highlighting a significant milestone in AI-driven female wellness technology that was recently honored with a CES Innovation Award.
Femto Technologies Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for its Sensera device design, marking a critical advancement in femtech innovation. The company's proprietary Smart Release System (SRS) technology, which integrates machine learning and artificial intelligence, underpins the device's unique approach to feminine wellness.
The patent allowance follows the device's recent recognition as a CES Innovation Awards® 2025 honoree in the AI category, underscoring its technological sophistication. Sensera aims to provide a holistic self-care experience that adapts to women's changing wellness needs through intelligent technology integration.
Yftah Ben Yaackov, CEO of Femto Technologies, emphasized the significance of the patent allowance, noting that it represents a major milestone in the company's mission to develop transformative wellness solutions. The Sensera device exemplifies the company's commitment to leveraging AI to enhance personal health technologies.
The patent protection will support Femto Technologies' continued research and development efforts, enabling the company to further refine its SRS technology and expand its portfolio of wellness-focused innovations. By securing intellectual property rights, the company can protect its technological advancements and potentially establish a stronger market position in the rapidly evolving femtech sector.